Jyothy Labs Limited has announced its intention to pursue legal remedies following the non-renewal of license agreements for the ‘Pril’ and ‘Fa’ brands by Henkel AG & Co. KGaA. After extensive discussions, the company has chosen to assert its contractual rights concerning the exit and transition mechanism. This decision follows a Board of Directors meeting on June 15, 2026, and the company will keep stakeholders updated on further developments.
Legal Action Initiated Over Brand Agreements
Jyothy Labs Limited has officially communicated its decision to initiate legal proceedings regarding the exit and transition mechanism of its license agreements for the ‘Pril’ and ‘Fa’ brands. This action comes after the non-renewal of these agreements by Henkel AG & Co. KGaA, as previously intimated on May 9, 2026.
Contractual Rights and Legal Strategy
Following comprehensive discussions and communication with Henkel, Jyothy Labs has evaluated all available options. The company has concluded that pursuing legal remedies is the necessary course of action to assert its contractual rights under the existing License Agreements and Technology License Agreements. This decision was finalized during a meeting of the Board of Directors held on June 15, 2026.
Agreement Details and Background
The original agreements, executed on May 31, 2011, covered the manufacturing, distribution, marketing, and sale of products under the ‘Pril’ and ‘Fa’ brands. The parties involved were Erstwhile Henkel India Limited (now amalgamated with Jyothy Labs Limited) and Henkel AG & Co. KGaA. Jyothy Labs Limited will continue to keep the Stock Exchanges informed of any material developments in this matter.
Source: BSE
